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INTRODUCTION
Lymphangioleiomyomatosis (LAM) is a rare disorder of
unknown cause that affects women of reproductive age. The
disorder is characterized by the proliferation of atypical
smooth muscle cells (LAM cells) around airways, blood
vessels, and lymphatics with cystic destruction of the lung.
1-3
LAM may occur sporadically or may be associated with
tuberous sclerosis complex (TSC).
1
Clinically, patients may develop progressive dyspnea,
cough, wheezing, spontaneous pneumothorax, chylothorax,
and hemoptysis.
3 The diagnosis is confirmed by the
identification of diffuse thin-walled lung cysts via thoracic
high resolution computed tomography (HRCT) that are
associated with a positive tissue biopsy or by the presence of
chylothorax, angiomyolipoma, or TSC.
1,2 Acute respiratory
failure that is secondary to diffuse alveolar hemorrhage is
an extremely rare manifestation in LAM patients, with only
two previous cases described. The mechanism responsible
for the comorbid presentation of acute respiratory failure
and diffuse alveolar hemorrhage, however, is unknown.
Nonetheless, it is speculated to be secondary to the
obstruction of pulmonary venules by LAM cell prolifera-
tion, thereby promoting pulmonary venous hypertension.
4,5
In the present work, we describe a patient with a diffuse
alveolar hemorrhage that led to acute respiratory failure and
death. A diagnosis of LAM and pulmonary arterial
disruption caused by LAM cells was confirmed during the
autopsy.
CASE DESCRIPTION
A 39-year-old woman of reproductive age presented with
progressive dyspnea and was being treated as an asthmatic
patient for seven years. A recent spirometry revealed a
moderate obstruction that did not respond to bronchodila-
tors. There was no history of cardiovascular comorbidity. In
the last month of the patient’s life, the dyspnea worsened,
and the patient complained of mild hemoptysis, which
required hospital admission. A chest examination revealed
a respiratory rate of 20/min and diffuse wheezing during
expiration without hypoxia.
The patient progressed to acute respiratory failure and
rapidly deteriorated with hypoxia. Mechanical ventilation
with positive end-expiratory pressure was necessary.
Laboratory studies revealed a decrease in the patient’s
hemoglobin levels from 10.4 to 6.7 g/dl. The patient’s white
blood cell count was 12,200/mm
3, with normal values for
the coagulation parameters. The patient’s blood sodium,
potassium, urea, creatinine, and glucose levels were within
normal ranges. The patient’s arterial blood gas on 60%
oxygen was PO2 68 mmHg, PCO2 45 mmHg, HCO3
2 20
mmol/l, a base excess-3,1 mmol/l, and a pH of 7.25. The
antinuclear antibody, anti-neutrophil cytoplasmic antibody,
and rheumatoid factor tests were all negative.
Thoracic computed tomography demonstrated bilateral
and diffuse ground-glass attenuation opacities, which were
predominant in the lower lobes of the lungs, and thin-
walled cysts (Figure 1). A bronchoscopic examination
revealed a moderate amount of blood in the segments of
both lungs, and the lavage aliquots were progressively more
hemorrhagic, which was consistent with the diagnosis of
diffuse alveolar hemorrhage. The patient developed hemo-
dynamic instability that resulted in the patient’s death.
A histological examination during the autopsy revealed
cystic lesions in the pulmonary tissue, with alveolar
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Figure 1 - Thoracic computed tomography. Bilateral and diffuse
ground-glass attenuation opacities predominant in the lower
lung lobes and thin-walled cystic lesions diffusely distributed in
both lungs, as identified using thoracic computed tomography.
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1301hemorrhaging and atypical smooth muscle cell proliferation
at the cyst wall (Figures 2A and 2B). These cells were
positive for antibodies against melanoma-associated antigen
(HMB-45) and alpha-smooth muscle actin in the immuno-
histochemical analysis, which is consistent with LAM
(Figures 2C and 2D). These HMB-45-positive LAM cells
were observed within the small pulmonary artery walls. A
disruption of the arterial elastic layer was also observed
(Figures 2E and 2F). Hemosiderin-laden macrophages in the
adjacent alveolar spaces were also identified (top right in
Figures 2E and 2F).
DISCUSSION
Due to the rarity of LAM and the non-specific symptoms
associated with this disease, it is common for patients with
LAM to have a delayed diagnosis or an incorrect diagnosis
of diseases such as asthma. When women of childbearing
age present with progressive dyspnea and spontaneous
pneumothorax, LAM should be considered as a potential
diagnosis. The likelihood of LAM increases if the HRCT
reveals thin-walled lung cysts and if an obstructive pattern is
observed through spirometry. HRCT can reveal abnormal-
ities in the chest radiograph before the identification of LAM,
and these abnormalities may vary from a few scattered cysts
to cysts that are diffusely distributed. Ground-glass opacities
may also be observed in HRCT, and hemorrhaging is a
mechanism that may be responsible for these abnormalities.
Other common clinical features associated with LAM include
the presence of chylothorax and chylous ascites and the
worsening of these ascites during pregnancy or after the
administration of estrogen.
1-3 The pathologic characteristics
of LAM include cysts and the multifocal nodular prolifera-
tion of immature smooth muscle cells and perivascular
epithelioid cells. In immunohistochemical analyses, these
muscle cells are positive for HMB-45 and alpha-actin. In
addition, the estrogen and/or progesterone receptor can be
detected using immunohistochemistry.
1
Figure 2 - Histological evaluation. Photomicrographs show pulmonary changes observed during the autopsy. A and B) Pulmonary tissue
with LAM cysts (*) associated with alveolar hemorrhage (he). Note the smooth muscle tissue proliferation at the cyst wall (B, arrow).
HMB-45 and alpha-smooth muscle actin-positive LAM cells at the cysts wall (arrows) are shown in C and D, respectively. E) HMB45-
positive LAM cells within the small pulmonary artery wall (arrows). F) Disruption of the arterial elastic layer (*). The adjacent alveolar
spaces indicate the presence of hemosiderin-laden macrophages (top right in E and F). A and B: H&E staining; C, D and E:
immunohistochemistry; F: Verhoeff staining. Scale bars = 50 mm.
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1302Acute respiratory failure that is secondary to diffuse
alveolar hemorrhage is a very rare manifestation in LAM
patients, with only two case reports to date.
4,5 The obstruc-
tion of pulmonary venules due to LAM cell proliferation,
promoting pulmonary venous hypertension, has been sug-
gested as the underlying mechanism of this manifestation.
1,5
The patient in the present case complained of mild
hemoptysis and had foci of hemosiderin-laden macrophages
in the alveoli, both of which were indicative of past
hemorrhaging. In the present case, however, we demon-
strated pulmonary arterial involvement by LAM cells with
the disruption of the arterial elastic layer, which may explain
the observed clinical emergency. The presence of venous
obstructions or any signs indicative of pulmonary hyperten-
sion were not found during the histological examination.
In conclusion, LAM should be included in the differential
diagnosis when a woman of reproductive age presents with
acute respiratory failure, a significant decrease in hemoglobin,
anddiffuseground-glassattenuationopacities.Thesesymptoms
are suggestive of diffuse alveolar hemorrhage combined with
bilateral thin-walled cysts in thoracic computed tomography.
To our knowledge, the present paper is the first report
of an LAM patient presenting with diffuse pulmonary
hemorrhage with a histological examination. Contrary to
previous speculations, we have shown that pulmonary
arterial involvement is likely the primary underlying factor
for this severe clinical presentation.
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